ампулы из партии препарата Laennec, отбракованные при инспекции на наличие посторонних включений
https://www.hindawi.com/journals/ecam/2012/732915/
The hydrolysate of human placenta (HPE; Laennec; Green Cross Japan Bio Products, Yongin, Korea) has been previously described [6]. It is an aqueous extract of human placenta that is approved by the Korea Food and Drug Administration for sale and use in the treatment of chronic liver diseases. To prepare the product, human placenta collected at the time of full-term delivery was immediately placed in ice. Each placenta is tested to ensure the absence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus. The acceptable placentas are cut into pieces and extracted with water through enzymatic molecular separation and chemical hydrolysis. Hydrolysis utilizes hydrochloric acid and heating for 15–17 hours. At the final process, the extract is sterilized by steam at 121°C for 30 minutes and sealed in ampoules for sale.

https://www.manufacturingchemist.com/news/article_page/Mettl...
The 0.8mm detector technology is said to be five times more sensitive to X-ray than traditional systems, ensuring unparalleled precision in the contaminant inspection of food and pharmaceutical products.